Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIV-1 reverse transcriptase (RT) is a multifunctional enzyme essential for the replication of the human immunodeficiency virus type 1 (HIV-1). It catalyzes the conversion of the viral single-stranded RNA genome into double-stranded DNA, which is then integrated into the host cell genome. This process, known as reverse transcription, is a hallmark of retroviral replication and is critical for viral propagation.
Inhibition of reverse transcriptase activity (DNA polymerase and/or RNase H)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reverse transcriptase of human immunodeficiency virus type 1 (HIV‑1 RT).